Polybio Research Foundation has awarded $29 million across 28 grants to 24 organizations between 2022 and 2024. Its giving concentrates in education. Its typical grant is $309,672, with most between $114,817 and $1,780,171. Repeat grantees receive a median $1,780,171 versus $250,000 for first-time grantees.
Each grantee's funding from this organization, summed across all reported years. Largest first — click any column to re-sort.
| Grantee | Total received | Grants | Years | Latest | State | Follow |
|---|---|---|---|---|---|---|
| U University of California San Francisco | $5.1M | 1 | 2023 | 2023 | — | — |
|
|
$4.2M | 3 | 2022–2024 | 2024 | CA | |
| M Mass General Brigham | $3.7M | 2 | 2022–2023 | 2023 | — | — |
|
|
$3.5M | 1 | 2024 | 2024 | NY | |
| R Regents of the University of California San Francisco | $3.2M | 1 | 2024 | 2024 | — | — |
| U University of Pennsylvania School of Medicine | $2.1M | 1 | 2024 | 2024 | — | — |
| U University of Pennsylvania Perelman School of Medicine | $1.7M | 1 | 2023 | 2023 | — | — |
| M Mount Sinai | $1.3M | 1 | 2022 | 2022 | TX | |
| N NYU Grossman School of Medicine | $1,000K | 1 | 2024 | 2024 | — | — |
| Y Yale Medical School | $917K | 1 | 2023 | 2023 | — | — |
| Y Yale University | $575K | 1 | 2024 | 2024 | — | — |
|
|
$345K | 1 | 2024 | 2024 | AZ | |
| R Regents of the University of Colorado | $304K | 1 | 2023 | 2023 | CO | |
| U Umass Chan Medical School | $250K | 1 | 2024 | 2024 | — | — |
| S Stratevi LLC | $201K | 1 | 2024 | 2024 | — | — |
| A Amici Lovanienses | $159K | 1 | 2024 | 2024 | — | — |
|
|
$129K | 1 | 2024 | 2024 | DC | |
| J Johns Hopkins University | $115K | 1 | 2022 | 2022 | — | — |
| B Brigham and Womens Hospital | $93K | 1 | 2024 | 2024 | — | — |
|
|
$68K | 1 | 2023 | 2023 | WA | |
| S Stanford University | $57K | 1 | 2024 | 2024 | — | — |
| S Serimmune | $30K | 1 | 2023 | 2023 | — | — |
| B Berkeley Labs | $16K | 1 | 2022 | 2022 | — | — |
| U University of Texas Southwestern | $11K | 1 | 2024 | 2024 | — | — |
Leave your email and we’ll let you know when you can finish signing in and follow the organization.
Try signing in anyway →